1 / 19

Pulmonary Echinococcus

Pulmonary Echinococcus. Megan Brundrett December 15, 2009. Pathology 1. Pathology 2. Echinococcus. Cestodes – divide their life cycle in 2 or more hosts Intermediate host – immature parasite as a tissue cyst Definitive host – mature parasite as a tapeworm Echinococcus granulosus

tawana
Download Presentation

Pulmonary Echinococcus

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pulmonary Echinococcus Megan Brundrett December 15, 2009

  2. Pathology 1

  3. Pathology 2

  4. Echinococcus • Cestodes – divide their life cycle in 2 or more hosts • Intermediate host – immature parasite as a tissue cyst • Definitive host – mature parasite as a tapeworm • Echinococcus granulosus • Echinococcus multilocularis

  5. E. granulosus • Hydatid disease • Definitive hosts are dogs or other canines • Intermediate hosts – sheep, goats, camels, horses, humans • Australia, New Zealand, Argentina, Chile, Ireland, Scotland, middle Europe, Kenya

  6. E. multilocularis • Alveolar disease • Definitive host – foxes, and other canines • Intermediate host – rodents, humans • Arctic areas of United States, Canada, and Russia

  7. Life Cycle • (1) Adult tapeworms in bowels of definitive host • (2) Eggs passed in feces, ingested by intermediate host • (3) Onchosphere penetrates intestinal wall, carried via blood vessels to lodge in organs • (4) Hydatid cysts develop • (5) Protoscolices (larvae) ingested by definitive host • (6) Attach to small intestine of definitive host and grow to adult worm.

  8. Hydatid disease • E. granulosus • 75% hepatic involvement, 25% pulmonary • Other organs – brain, bone, heart, kidney • Cause symptoms with mass effect, rupture, secondary infection

  9. Alveolar disease • E. multilocularis • < 5% of symptomatic Echinococcal infections • Lacks a limiting membrane like hydatid disease and causes more infiltration to surrounding tissues. • Clinical presentation – jaundice, RUQ pain, malaise • If untreated >90% die within 10 years • Now prognosis improved b/c of albendazole therapy. Very difficult to surgically resect.

  10. Pulmonary Echinococcal Diease • 60% right lung • 50-60% in lower lobes • Lungs may be a more common site in children • 30% have multiple cysts in the lungs • 20% of pts with lung involvement have liver involvement

  11. Clinical Manifestations • Unruptured cyst: Chest pain, hemoptysis, chronic cough • Ruptured cyst: Cough, fever, expectorating salty material (hydatid membrane and larvae). • Acute hypersensitivity with rupture: Fever, urticaria, sometimes anaphylaxis • Superinfection by bacteria, fungal presenting with fever, sepsis • Pulmonary HTN, Pulmonary embolism

  12. Diagnosis • CXR: Round or oval mass with smooth borders. No calcifications. If pericyst (fibrous capsule that host makes) incorporates bronchioles, than air penetrates between the pericyst and exocyst creating a meniscus sign or crescent shape. • CT scan: Thin enhancing ring if cyst is intact. Fluid filled in center. Homogenous.

  13. CXR

  14. Differential Diagnosis • Primary lung cancer • Metastatic cancer • Tuberculosis • Bronchogenic Cyst • Round pneumonia • Aspergillosis

  15. Laboratory Data • Less than 15% have peripheral eosinophilia, only if leakage of antigenic material • Immunodiagnostic testing for serum antibodies: + 50% for pulmonary, > 90% for hepatic - False positive if have another parasitic infection - More likely to have false negative if intact cyst • Percutaneous aspiration: Not often use in pulmonary echinococcus, but used with hepatic cysts for diagnosis and treatment. Fluid contains hooklets, protoscolices, etc.

  16. Management • Surgical resection: Treatment of choice • Minimize spilling of contents to prevent spread, and allergic reaction • Intact cyst • Cystic fluid aspiration, and scolicidal solution (hypertonic saline) for deactivation • Recurrance rate after removal 1-3%

  17. Management 2 • Chemotherapy: Used with poor surgical candidate, unresectable lesion, multiple cysts, after cyst rupture, or if intraoperative spillage • Prior to surgery reduces tension of cyst • Albendazole 400 mg PO BID • Length of treatment 3-6 months • No established monitoring guidelines for response of therapy • Disappearance of cysts in 30%, decrease in size in 30-50%, no change in 20% • 25% relapse rate, more common with multiple cysts, children and elderly adults

  18. Prevention • Avoiding close contacts with dogs • Careful washing of hands, and produce • Prohibition of home slaughter of sheep and to prevent dogs from eating the infected viscera • Treating infected dogs with Praziquantal • Eliminating stray dogs • Vaccination: Appears to be 95% effective in animal studies, not used on humans currently

  19. References • “Clinical manifestations and diagnosis of cystic and alveolar echinococcosis.” UptoDate. 2009.<www.uptodate.com> • Goldman, Lee et al. Cecil Textbook of Medicine. Philadephia: Saunders, 2004. • Morar,R and Feldman,C. Eur Respir J 2003; 21: 1069-1077. • “Treatment and prevention of echinococcus.” UptoDate. 2009.<www.uptodate.com>

More Related